TRIANA Biomedicines
Rosaline Yuan-Chieh Hsu is a scientist at TRIANA Biomedicines since March 2023, with prior experience as a postdoctoral research fellow at Massachusetts General Hospital from September 2020 to March 2023. Hsu's academic journey includes a Doctor of Philosophy in Cell and Developmental Biology from the University of Illinois at Urbana-Champaign, during which time Hsu served as a graduate research assistant from August 2013 to September 2020. Earlier research experience includes a role as a research assistant at National Chung Hsing University and an internship as a medical technologist at Taipei Veterans General Hospital. Hsu's work has focused on the role of ADD1 (alpha-adducin) in mitotic spindle assembly.
This person is not in any offices
TRIANA Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.